Mitsubishi UFJ Asset Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,480
| Closed | -$180K | – | 1110 |
|
|
2023
Q1 | $180K | Hold |
2,480
| – | – | ﹤0.01% | 1033 |
|
|
2022
Q4 | $203K | Buy |
2,480
+522
| +27% | +$42.8K | ﹤0.01% | 1016 |
|
|
2022
Q3 | $185K | Buy |
1,958
+37
| +2% | +$3.5K | ﹤0.01% | 1033 |
|
|
2022
Q2 | $374K | Buy |
1,921
+1,232
| +179% | +$240K | ﹤0.01% | 968 |
|
|
2022
Q1 | $160K | Buy |
689
+44
| +7% | +$10.2K | ﹤0.01% | 1085 |
|
|
2021
Q4 | $272K | Sell |
645
-227
| -26% | -$95.7K | ﹤0.01% | 1030 |
|
|
2021
Q3 | $390K | Buy |
872
+23
| +3% | +$10.3K | ﹤0.01% | 974 |
|
|
2021
Q2 | $330K | Buy |
849
+186
| +28% | +$72.3K | ﹤0.01% | 1023 |
|
|
2021
Q1 | $238K | Buy |
663
+199
| +43% | +$71.4K | ﹤0.01% | 974 |
|
|
2020
Q4 | $228K | Sell |
464
-221
| -32% | -$109K | ﹤0.01% | 941 |
|
|
2020
Q3 | $222K | Sell |
685
-1
| -0.1% | -$324 | ﹤0.01% | 886 |
|
|
2020
Q2 | $250K | Buy |
686
+193
| +39% | +$70.3K | ﹤0.01% | 858 |
|
|
2020
Q1 | $105K | Buy |
493
+89
| +22% | +$19K | ﹤0.01% | 929 |
|
|
2019
Q4 | $162K | Buy |
404
+171
| +73% | +$68.6K | ﹤0.01% | 906 |
|
|
2019
Q3 | $82K | Buy |
233
+34
| +17% | +$12K | ﹤0.01% | 922 |
|
|
2019
Q2 | $100K | Buy |
199
+17
| +9% | +$8.54K | ﹤0.01% | 917 |
|
|
2019
Q1 | $181K | Buy |
182
+20
| +12% | +$19.9K | ﹤0.01% | 811 |
|
|
2018
Q4 | $115K | Buy |
162
+39
| +32% | +$27.7K | ﹤0.01% | 828 |
|
|
2018
Q3 | $127K | Buy |
+123
| New | +$127K | ﹤0.01% | 824 |
|